Smart Insulin Pen Helps Users Make Better Dosing Decisions
By HospiMedica International staff writers Posted on 26 Nov 2020 |
Image: The InPen smart insulin pen and Companion app (Photo courtesy of Medtronic)
An integrated system provides real-time glucose readings alongside insulin dose information for people on multiple daily injections (MDI).
The Medtronic (Dublin, Ireland) InPen with Guardian Connect links wirelessly to a smartphone device in order to provide dosing calculations and reminders, integrating concomitantly with continuous glucose monitoring (CGM) systems. The companion app tracks insulin doses, active insulin, and recommendations on meal time and correct dosing. The integration with Medtronic CGMs allows patients to see all their information in one view, and share the data with caregivers and clinicians.
The InPen is compatible with short-acting Humalog, Novolog, and Fiasp U-100 3.0 mL insulin cartridges. The InPen app also allows users to manually log long-acting insulin doses and set up dose reminders. A built-in customizable calculator helps choose among three different modes, based on carbohydrate content. Additional features include temperature monitoring, an automated month-long notebook, and integration with most Bluetooth-connected glucose meters. Multiple InPens can be connected to a single app.
“We’re pleased to build on the success of InPen with added real-time glucose data, which provides a complete picture for users as they look to give themselves the right dose of insulin at the right time,” said Sean Salmon, executive VP and president of the diabetes business at Medtronic. “Our successful integration of these devices in just two months following the close of Companion Medical acquisition is a testament to the close collaboration of our employees and strong passion to serve our customers with better solutions to manage their diabetes.”
The traditional standard-of-care for glucose monitoring is a finger stick meter. CGM thus represents the most significant breakthrough in diabetes management in the past 40 years, augmenting the use of glucose meters for the management of diabetes by providing real-time glucose changes with the push of a button, alerting users when glucose is too low or too high.
The Medtronic (Dublin, Ireland) InPen with Guardian Connect links wirelessly to a smartphone device in order to provide dosing calculations and reminders, integrating concomitantly with continuous glucose monitoring (CGM) systems. The companion app tracks insulin doses, active insulin, and recommendations on meal time and correct dosing. The integration with Medtronic CGMs allows patients to see all their information in one view, and share the data with caregivers and clinicians.
The InPen is compatible with short-acting Humalog, Novolog, and Fiasp U-100 3.0 mL insulin cartridges. The InPen app also allows users to manually log long-acting insulin doses and set up dose reminders. A built-in customizable calculator helps choose among three different modes, based on carbohydrate content. Additional features include temperature monitoring, an automated month-long notebook, and integration with most Bluetooth-connected glucose meters. Multiple InPens can be connected to a single app.
“We’re pleased to build on the success of InPen with added real-time glucose data, which provides a complete picture for users as they look to give themselves the right dose of insulin at the right time,” said Sean Salmon, executive VP and president of the diabetes business at Medtronic. “Our successful integration of these devices in just two months following the close of Companion Medical acquisition is a testament to the close collaboration of our employees and strong passion to serve our customers with better solutions to manage their diabetes.”
The traditional standard-of-care for glucose monitoring is a finger stick meter. CGM thus represents the most significant breakthrough in diabetes management in the past 40 years, augmenting the use of glucose meters for the management of diabetes by providing real-time glucose changes with the push of a button, alerting users when glucose is too low or too high.
Latest Critical Care News
- Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients
- Peptide-Based Hydrogels Repair Damaged Organs and Tissues On-The-Spot
- One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes
- AI Can Prioritize Emergecny Department Patients Requiring Urgent Treatment
- AI to Improve Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure